The National Institute on Drug Abuse (NIDA) of the National Institute of Health gave Weill Cornell Medicine a five-year, $11.6 million grant to research how marijuana affects the brains of HIV patients.

“We know that the virus may cause changes within the brain, but it’s not clear yet how the use of cannabis might interact with the infection,” said principal investigator Dr. Lishomwa Ndhlovu, professor of Immunology in Medicine in the Infectious Diseases Division at Weill Cornell Medicine. 

The scientists leave both possibilities open – for marijuana to boost HIV’s negative effects on the brain or protect against them.“This support from NIDA will allow us to collect the data we need to explore this relationship,” …

Full story available on

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.